Huiliao Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series B

  • Investors
  • 11

Huiliao General Information

Description

Developer of nucleic acid drugs intended to bring more mRNA innovative drugs to the clinic to benefit patients. The company specialises in mRNA drug development and production, clinical trial design, and data analysis, providing customers with infectious disease vaccines, tumour vaccines, cell therapy and protein substitution based on mRNA technology.

Contact Information

Website
www.healrna.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 3rd Floor, Building B3
  • Number 88, Dongchang Road, Suzhou Industrial Park
  • Suzhou, Jiangsu
  • China
+86 0512
Primary Industry
Pharmaceuticals
Vertical(s)
Corporate Office
  • 3rd Floor, Building B3
  • Number 88, Dongchang Road, Suzhou Industrial Park
  • Suzhou, Jiangsu
  • China
+86 0512

Huiliao Timeline

2023202420252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Huiliao Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Early Stage VC (Series B) 04-Sep-2025 Completed Generating Revenue
4. Early Stage VC 15-Apr-2025 Completed Pre-Clinical Trials
3. Early Stage VC (Series A) 14-Jan-2025 Completed Pre-Clinical Trials
2. Early Stage VC 10-Mar-2023 $14.5M $30M Completed Pre-Clinical Trials
1. Seed Round 21-Sep-2021 $15.5M $15.5M Completed Pre-Clinical Trials
To view Huiliao’s complete valuation and funding history, request access »

Huiliao Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
Leader Venture Capital Growth/Expansion Minority
Nantong Zijin Capital Management Growth/Expansion Minority
Shenzhen Guozhong Venture Capital Management Venture Capital Minority
Vazyme Biotech Corporation Minority
AAMA Angel Fund Venture Capital Minority
You’re viewing 5 of 11 investors. Get the full list »

Huiliao FAQs

  • When was Huiliao founded?

    Huiliao was founded in 2021.

  • Where is Huiliao headquartered?

    Huiliao is headquartered in Suzhou, China.

  • What industry is Huiliao in?

    Huiliao’s primary industry is Pharmaceuticals.

  • Is Huiliao a private or public company?

    Huiliao is a Private company.

  • What is Huiliao’s current revenue?

    The current revenue for Huiliao is .

  • How much funding has Huiliao raised over time?

    Huiliao has raised $43.7M.

  • Who are Huiliao’s investors?

    Leader Venture Capital, Nantong Zijin Capital Management, Shenzhen Guozhong Venture Capital Management, Vazyme Biotech, and AAMA Angel Fund are 5 of 11 investors who have invested in Huiliao.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process